多发性-话题@MedSci

#多发性#

905篇内容 | 2956人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1890203, encodeId=1d1a189020352, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurology：继发性进展性多发性硬化临床试验的可靠性, objectType=article, longId=205610, objectId=903d20561035, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=903d20561035, replyNumber=0, likeNumber=80, createdTime=2021-11-04, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=903d20561035, moduleTitle=Neurology：继发性进展性多发性硬化临床试验的可靠性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=903d20561035)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890181, encodeId=ee43189018155, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JCO：18F-FDG–PET/CT定义多发性骨髓瘤代谢完全缓解的标准, objectType=article, longId=203008, objectId=53e32030088f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53e32030088f, replyNumber=0, likeNumber=81, createdTime=2021-08-12, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53e32030088f, moduleTitle=JCO：18F-FDG–PET/CT定义多发性骨髓瘤代谢完全缓解的标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53e32030088f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890263, encodeId=579d18902637b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JCO: Ixazomi联合来那度胺+地塞米松治疗复发或难治性多发性骨髓瘤（RRMM）的最终分析结果：III期临床研究TOURMALINE-MM1, objectType=article, longId=212671, objectId=87bb2126e1d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87bb2126e1d5, replyNumber=0, likeNumber=54, createdTime=2021-07-10, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87bb2126e1d5, moduleTitle=JCO: Ixazomi联合来那度胺+地塞米松治疗复发或难治性多发性骨髓瘤（RRMM）的最终分析结果：III期临床研究TOURMALINE-MM1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87bb2126e1d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890207, encodeId=bad1189020e6b, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=消灭癌症干细胞，小鼠多发性骨髓瘤得到治疗, objectType=article, longId=205971, objectId=33772059e1f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33772059e1f8, replyNumber=0, likeNumber=71, createdTime=2021-04-29, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33772059e1f8, moduleTitle=消灭癌症干细胞，小鼠多发性骨髓瘤得到治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33772059e1f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890237, encodeId=96da189023efe, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Br J Cancer：ITGA6表达下调增强多发性骨髓瘤的侵袭作用并促进其发展为浆细胞白血病, objectType=article, longId=209342, objectId=a2c5209342f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a2c5209342f7, replyNumber=0, likeNumber=76, createdTime=2021-10-24, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a2c5209342f7, moduleTitle=Br J Cancer：ITGA6表达下调增强多发性骨髓瘤的侵袭作用并促进其发展为浆细胞白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2c5209342f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890221, encodeId=3f0f189022192, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Eur Radiol: 骨髓ADC值是否可指导临床预测多发性骨髓瘤患者的预后？, objectType=article, longId=207430, objectId=656c20e43021, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=656c20e43021, replyNumber=0, likeNumber=72, createdTime=2021-09-05, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=656c20e43021, moduleTitle=Eur Radiol: 骨髓ADC值是否可指导临床预测多发性骨髓瘤患者的预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=656c20e43021)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890267, encodeId=3cc5189026ea3, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Neurol Neuroimmunol Neuroinflamm: 结构和功能MRI网络可预测多发性硬化症临床恶化, objectType=article, longId=213125, objectId=c57e213125d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c57e213125d1, replyNumber=0, likeNumber=74, createdTime=2022-04-04, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c57e213125d1, moduleTitle=Neurol Neuroimmunol Neuroinflamm: 结构和功能MRI网络可预测多发性硬化症临床恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c57e213125d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890239, encodeId=5525189023999, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:线性法测量多发性硬化和临床孤立综合征的脑萎缩：一项30年随访研究, objectType=article, longId=209928, objectId=29c420992840, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29c420992840, replyNumber=0, likeNumber=0, createdTime=2021-11-18, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29c420992840, moduleTitle=JNNP:线性法测量多发性硬化和临床孤立综合征的脑萎缩：一项30年随访研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29c420992840)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890257, encodeId=974b189025eb9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Ann Hematol：多发性骨髓瘤移植后依沙佐米维持治疗中不良事件的管理, objectType=article, longId=212028, objectId=e46e21202860, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e46e21202860, replyNumber=0, likeNumber=80, createdTime=2021-06-25, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e46e21202860, moduleTitle=Ann Hematol：多发性骨髓瘤移植后依沙佐米维持治疗中不良事件的管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e46e21202860)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890227, encodeId=5ffb189022ebb, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=北京病痛挑战公益基金会携手诺华制药联合发布全国首部多发性硬化患者纪录片《让爱可及》, objectType=article, longId=207774, objectId=d8ba20e774c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8ba20e774c7, replyNumber=0, likeNumber=69, createdTime=2021-06-07, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8ba20e774c7, moduleTitle=北京病痛挑战公益基金会携手诺华制药联合发布全国首部多发性硬化患者纪录片《让爱可及》, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8ba20e774c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890196, encodeId=4a4c1890196dd, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Br J Cancer：逆转多发性骨髓瘤耐药性的替代策略, objectType=article, longId=204413, objectId=892c204413da, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=892c204413da, replyNumber=0, likeNumber=82, createdTime=2021-08-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=892c204413da, moduleTitle=Br J Cancer：逆转多发性骨髓瘤耐药性的替代策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=892c204413da)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890253, encodeId=23371890253d2, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=J Neurol Neurosur Ps：复发性和进行性多发性硬化症风险的影响因素, objectType=article, longId=211781, objectId=f2fa211e8184, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2fa211e8184, replyNumber=0, likeNumber=64, createdTime=2021-09-16, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2fa211e8184, moduleTitle=J Neurol Neurosur Ps：复发性和进行性多发性硬化症风险的影响因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2fa211e8184)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890168, encodeId=b3101890168f5, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Leukemia：多发性骨髓瘤的异基因移植治疗效果, objectType=article, longId=201791, objectId=f028201e9172, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f028201e9172, replyNumber=0, likeNumber=132, createdTime=2021-07-02, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f028201e9172, moduleTitle=Leukemia：多发性骨髓瘤的异基因移植治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f028201e9172)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890198, encodeId=2133189019887, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=骨髓瘤治疗新进展，全新作用机制药物Selinexor（ATG-010）三种治疗方案入选更新版NCCN®多发性骨髓瘤诊疗指南, objectType=article, longId=204590, objectId=39b1204590b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39b1204590b5, replyNumber=0, likeNumber=0, createdTime=2021-10-20, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39b1204590b5, moduleTitle=骨髓瘤治疗新进展，全新作用机制药物Selinexor（ATG-010）三种治疗方案入选更新版NCCN®多发性骨髓瘤诊疗指南, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39b1204590b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890231, encodeId=bdad18902313a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:多发性硬化病因学中的DRB1与环境相互作用：来自两项瑞典病例对照研究的结果, objectType=article, longId=208746, objectId=f513208e46aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f513208e46aa, replyNumber=0, likeNumber=92, createdTime=2022-01-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f513208e46aa, moduleTitle=JNNP:多发性硬化病因学中的DRB1与环境相互作用：来自两项瑞典病例对照研究的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f513208e46aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890279, encodeId=420318902e98f, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP:神经轴突定向离散度与密度成像揭示了儿童多发性硬化正常白质的早期变化, objectType=article, longId=214367, objectId=e30621436e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e30621436e5a, replyNumber=0, likeNumber=74, createdTime=2021-09-23, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e30621436e5a, moduleTitle=JNNP:神经轴突定向离散度与密度成像揭示了儿童多发性硬化正常白质的早期变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e30621436e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890247, encodeId=8682189024e25, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=Lancet Haematol：联合输注人源化抗CD19和抗BCMA CAR T细胞或是治疗复发或难治性多发性骨髓瘤的一种新疗法, objectType=article, longId=211074, objectId=1a872110e4ea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a872110e4ea, replyNumber=0, likeNumber=71, createdTime=2021-07-05, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a872110e4ea, moduleTitle=Lancet Haematol：联合输注人源化抗CD19和抗BCMA CAR T细胞或是治疗复发或难治性多发性骨髓瘤的一种新疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1a872110e4ea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890228, encodeId=945e1890228ef, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=BLOOD：好消息！ISAtuximab 联合地塞米松治疗复发/难治性多发性骨髓瘤可提高ORR, objectType=article, longId=207913, objectId=49ca20e9132b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49ca20e9132b, replyNumber=0, likeNumber=64, createdTime=2021-09-21, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49ca20e9132b, moduleTitle=BLOOD：好消息！ISAtuximab 联合地塞米松治疗复发/难治性多发性骨髓瘤可提高ORR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49ca20e9132b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890163, encodeId=ed4a1890163d4, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=多发性硬化症药物或添新成员：FDA批准ANK-700治疗多发性硬化症的IND, objectType=article, longId=201325, objectId=718d20132547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=718d20132547, replyNumber=0, likeNumber=98, createdTime=2021-08-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=718d20132547, moduleTitle=多发性硬化症药物或添新成员：FDA批准ANK-700治疗多发性硬化症的IND, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=718d20132547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1890205, encodeId=2ee618902055a, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, objectTitle=JNNP：神经突起密度解释多发性硬化皮质T1加权/T2加权比值, objectType=article, longId=205863, objectId=bd602058639f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd602058639f, replyNumber=0, likeNumber=82, createdTime=2021-11-06, rootId=0, userName=jml2009, userId=04d6114, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd602058639f, moduleTitle=JNNP：神经突起密度解释多发性硬化皮质T1加权/T2加权比值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd602058639f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

多发性

2020-05-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurology：继发性进展性多发性硬化临床试验的可靠性

2021-11-04

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JCO：18F-FDG–PET/CT定义多发性骨髓瘤代谢完全缓解的标准

2021-08-12

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JCO: Ixazomi联合来那度胺+地塞米松治疗复发或难治性多发性骨髓瘤（RRMM）的最终分析结果：III期临床研究TOURMALINE-MM1

2021-07-10

jml2009 (审核中...)

前往app查看评论内容

#多发性#

消灭癌症干细胞，小鼠多发性骨髓瘤得到治疗

2021-04-29

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Br J Cancer：ITGA6表达下调增强多发性骨髓瘤的侵袭作用并促进其发展为浆细胞白血病

2021-10-24

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Eur Radiol: 骨髓ADC值是否可指导临床预测多发性骨髓瘤患者的预后？

2021-09-05

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Neurol Neuroimmunol Neuroinflamm: 结构和功能MRI网络可预测多发性硬化症临床恶化

2022-04-04

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:线性法测量多发性硬化和临床孤立综合征的脑萎缩：一项30年随访研究

2021-11-18

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Ann Hematol：多发性骨髓瘤移植后依沙佐米维持治疗中不良事件的管理

2021-06-25

jml2009 (审核中...)

前往app查看评论内容

#多发性#

北京病痛挑战公益基金会携手诺华制药联合发布全国首部多发性硬化患者纪录片《让爱可及》

2021-06-07

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Br J Cancer：逆转多发性骨髓瘤耐药性的替代策略

2021-08-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

J Neurol Neurosur Ps：复发性和进行性多发性硬化症风险的影响因素

2021-09-16

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Leukemia：多发性骨髓瘤的异基因移植治疗效果

2021-07-02

jml2009 (审核中...)

前往app查看评论内容

#多发性#

骨髓瘤治疗新进展，全新作用机制药物Selinexor（ATG-010）三种治疗方案入选更新版NCCN®多发性骨髓瘤诊疗指南

2021-10-20

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:多发性硬化病因学中的DRB1与环境相互作用：来自两项瑞典病例对照研究的结果

2022-01-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP:神经轴突定向离散度与密度成像揭示了儿童多发性硬化正常白质的早期变化

2021-09-23

jml2009 (审核中...)

前往app查看评论内容

#多发性#

Lancet Haematol：联合输注人源化抗CD19和抗BCMA CAR T细胞或是治疗复发或难治性多发性骨髓瘤的一种新疗法

2021-07-05

jml2009 (审核中...)

前往app查看评论内容

#多发性#

BLOOD：好消息！ISAtuximab 联合地塞米松治疗复发/难治性多发性骨髓瘤可提高ORR

2021-09-21

jml2009 (审核中...)

前往app查看评论内容

#多发性#

多发性硬化症药物或添新成员：FDA批准ANK-700治疗多发性硬化症的IND

2021-08-06

jml2009 (审核中...)

前往app查看评论内容

#多发性#

JNNP：神经突起密度解释多发性硬化皮质T1加权/T2加权比值

2021-11-06

科室
- - 订阅+
  - 更多科室
工具
服务